NASDAQ:CCXI

Chemocentryx Stock Predictions

etoro logo Buy CCXI
*Your capital is at risk
$10.24
+0.0150 (+0.147%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CCXI Prediction Chart

CCXI Predictions History

Latest community submissions for CCXI.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 26, 2022 Bullish $51.62 X 0
JS JS Pro
Oct 12, 2021 $38.16 +6.00% $36.00 X 94.00% 1
Oct 12, 2021 Bullish $36.00 X 0
JS JS Pro
May 10, 2021 $14.68 +33.82% $10.97 X 66.18% 1
May 10, 2021 $33.49 +205.29% Unrealistic Excluded from avg $10.97 X 0.00% 1
Mar 4, 2020 Bullish $50.78 X 1
Eitan Yehoshua Eitan Yehoshua @EitanYehoshua.133763
Feb 6, 2020 Bearish $47.80 X 0
JS JS Pro
Feb 5, 2020 $45.82 -2.84% $47.16 X 97.16% 1
2poJeff 2poJeff Pro
Feb 5, 2020 $44.98 -4.62% $47.16 X 95.38% 1
Feb 5, 2020 $44.89 -4.81% $47.16 X 95.19% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CCXI with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CHEMOCENTRYX INC
ChemoCentryx
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE